Kromek Group PLC Further agreement with Smiths Detection (0775K)
December 19 2022 - 1:00AM
UK Regulatory
TIDMKMK
RNS Number : 0775K
Kromek Group PLC
19 December 2022
19 December 2022
Kromek Group plc
("Kromek" or the "Group")
Kromek enters further agreement with Smiths Detection
Significant expansion of agreement to include distribution of
Kromek's radiation detection solutions in the Middle East and
certain markets in Asia and Australasia
Kromek Group plc (AIM: KMK) , a leading developer of radiation
and bio-detection technology solutions for the advanced imaging and
CBRN detection segments, is pleased to announce that it has entered
into a distribution agreement with Smiths Detection, a global
leader in threat detection and security screening technologies.
Under the terms of the agreement, Smiths Detection will market
and distribute the Group's wearable radiation detection and
identification solutions in the Middle East and certain key markets
in Asia and Australasia. This expands the Group's existing
agreement, as announced on 7 July 2022, with Smiths Detection Inc.
for distribution in North and South American markets. To date, the
Group has delivered over 1,000 detectors under this
partnership.
Arnab Basu, CEO of Kromek Group, said: "We are pleased to be
expanding our agreement with Smiths Detection to include the
distribution and marketing of our solutions to the Middle East and
parts of Asia and Australasia. This underscores the strength of our
relationship and is a great endorsement of our products. With
security forces globally requiring increasingly sophisticated
solutions to guard against the threats of nuclear terrorism and the
illicit movement of materials, the demand for our high-performance
nuclear security products continues to grow."
Michael Lea, Global Director Defence of Smiths Detection, added
" Smiths Detection are delighted to have entered into an agreement
with Kromek to distribute their world-class products. We believe
that they will meet the requirements of many customers across many
different markets and will add a new dimension to the range of
products available from Smiths Detection."
ENDS
For further information, please contact:
Kromek Group plc
Arnab Basu, CEO
Paul Farquhar, CFO +44 (0)1740 626 060
finnCap Ltd (Nominated Adviser and Broker)
Geoff Nash/Seamus Fricker/George Dollemore
- Corporate Finance
Tim Redfern/Charlotte Sutcliffe - ECM +44 (0)20 7220 0500
Gracechurch Group (Financial PR)
Harry Chathli, Claire Norbury +44 (0)20 4582 3500
Kromek Group plc
Kromek Group plc is a leading developer of radiation detection
and bio-detection technology solutions for the advanced imaging and
CBRN detection segments. Headquartered in County Durham, UK, Kromek
has manufacturing operations in the UK and US, delivering on the
vision of enhancing the quality of life through innovative
detection technology solutions.
The advanced imaging segment comprises the medical (including CT
and SPECT), security and industrial markets. Kromek provides its
OEM customers with detector components, based on its core cadmium
zinc telluride (CZT) platform, to enable better detection of
diseases such as cancer and Alzheimer's, contamination in
industrial manufacture and explosives in aviation settings.
In CBRN detection, the Group provides nuclear radiation
detection solutions to the global homeland defence and security
market. Kromek's compact, handheld, high-performance radiation
detectors, based on advanced scintillation technology, are
primarily used to protect critical infrastructure and urban
environments from the threat of 'dirty bombs'.
The Group is also developing bio-security solutions in the CBRN
detection segment. These consist of fully automated and autonomous
systems to detect a wide range of airborne pathogens.
Kromek is listed on AIM, a market of the London Stock Exchange,
under the trading symbol 'KMK'.
Further information is available at www.kromek.com .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
AGRKVLFFLLLXFBF
(END) Dow Jones Newswires
December 19, 2022 02:00 ET (07:00 GMT)
Kromek (LSE:KMK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Kromek (LSE:KMK)
Historical Stock Chart
From Jul 2023 to Jul 2024